Wave Life Sciences annual ebitda
2013
2014
2015
2016
2017
Wave Life Sciences EBITDA Growth & History (WVE)
Wave Life Sciences's calculated EBITDA was −$100.2M for fiscal 2017.
View full Wave Life Sciences company overviewWave Life Sciences annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2017 | 2017-12-31 | −$100.2M | −$45.3M | — |
| 2016 | 2016-12-31 | −$54.9M | −$36.2M | — |
| 2015 | 2015-12-31 | −$18.7M | −$13.6M | — |
| 2014 | 2014-12-31 | −$5.1M | −$1.8M | — |
| 2013 | 2013-12-31 | −$3.3M | — | — |
Wave Life Sciences quarterly ebitda
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q4 2016 | 2016-12-31 | −$18.6M | −$11.6M | — |
| Q3 2016 | 2016-09-30 | −$17.0M | −$12.3M | — |
| Q2 2016 | 2016-06-30 | −$11.5M | −$7.9M | — |
| Q1 2016 | 2016-03-31 | −$7.8M | −$4.4M | — |
| Q4 2015 | 2015-12-31 | −$7.1M | −$5.8M | — |
| Q3 2015 | 2015-09-30 | −$4.7M | — | — |
| Q2 2015 | 2015-06-30 | −$3.5M | — | — |
| Q1 2015 | 2015-03-31 | −$3.4M | — | — |
| Q3 2014 | 2014-09-30 | −$1.3M | — | — |
Wave Life Sciences ebitda trends
Across the available reported history, Wave Life Sciences's ebitda decreased from −$54.9M to −$100.2M, a change of −$45.3M. The latest reported quarter, Q4 2016, shows −$18.6M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Wave Life Sciences filings at SEC.gov ↗